Profile
Itzhak D.
Goldberg is the founder of Angion Biomedica Corp.
which was founded in 1998.
He held the titles of Executive Chairman & Chief Scientific Officer from 2018 to 2022.
Dr. Goldberg's former job was as a Professor-Radiation Oncology at Albert Einstein College of Medicine, Inc. Dr. Goldberg received his doctorate degree from Albert Einstein College of Medicine, Inc. in 1976.
Former positions of Itzhak D. Goldberg
| Companies | Position | End |
|---|---|---|
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
| ANGN BIOM | Chief Executive Officer | 2018-02-28 |
Training of Itzhak D. Goldberg
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- Itzhak D. Goldberg
